ADC Therapeutics.
company in Épalinges, Switzerland
- Reports this week
- 0
- Active events
- 0
- Connections
- 16
What's happening
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
What's reaching ADC Therapeutics
Events traced to ADC Therapeutics, step by step, newest first- ADC Therapeutics may benefit from reduced competition in wet AMD treatmentADC Therapeutics may benefit from reduced competition in wet AMD treatment.Possible
- Nxera's APAC expansion may intensify competition for ADC TherapeuticsNxera's APAC expansion may intensify competition for ADC TherapeuticsPossible
Around ADC Therapeutics this week
News at the entities that move ADC Therapeutics most-
FDA StructuralFDA conducted surprise raids and inspections in Bihar state, directed by state government officials.Moves ADC Therapeutics
-
European Commission StructuralMureșan supports the EU's global vision as the Commission centers the bloc in Brussels amid Canada's geopolitical shift.Moves ADC Therapeutics
-
New Jersey Shared contextKevin Connolly watched a movie in his New Jersey home while his collection is being auctioned in Los Angeles.Moves ADC Therapeutics
-
Nasdaq Shared contextVMware's stock performance was tracked on the Nasdaq exchange on October 25, 2026.Moves ADC Therapeutics
-
London Shared contextIndustry leaders met in London to discuss oil prices rising due to the ongoing war in Iran.Moves ADC Therapeutics
-
Switzerland Shared contextAuthor traveled through Swiss mountains, highlighting tourism promotion in the Bettmeralp region.Moves ADC Therapeutics
Connections
The 12 strongest of 16, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
ADC Therapeutics' drug development and commercial status are fundamentally governed by regulatory actions and approvals from the FDA.
-
Mohamed Zaki Structural
Mohamed Zaki serves as the Chief Medical Officer for ADC Therapeutics.
-
European Commission Structural
ADC Therapeutics received conditional approval for ZYNLONTA from the European Commission.
-
Lugano Shared context
ADC Therapeutics conducts research and presentations in Lugano, utilizing local criteria for response assessment.
-
New Jersey Shared context
ADC Therapeutics conducts business operations within the geographical boundaries of New Jersey.
-
Nxera Pharma Operational
The companies are actively competing in the market, as evidenced by direct comparisons of their financial and market performance.
-
Nasdaq Shared context
ADC Therapeutics is listed and trades on the Nasdaq market platform.
-
London Shared context
ADC Therapeutics maintains operational presence within London.
Show all 12 connections
-
Lausanne Shared context
ADC Therapeutics is headquartered in Lausanne, Switzerland.
-
Switzerland Shared context
ADC Therapeutics is a company based and operating within Switzerland.
-
Milan Shared context
ADC Therapeutics conducts clinical trials and presents data within Milan.
-
Italy Shared context
ADC Therapeutics conducts clinical trials and presents data within Italy.